Jesse Kigozi

Jesse Kigozi is an Associate Professor in the Health Economics Unit of the School of Applied Health Sciences, specializing in health economic evaluations within clinical trials for chronic disease management and primary care interventions.

His core research domains include:

• Cost-effectiveness analysis of vascular revascularization strategies
• Opioid stewardship programs in primary care settings
• Optimal timing interventions for hypertensive disorders in pregnancy
• Musculoskeletal pain management and injection therapies

Recent publications (2023-2025) reveal a concentrated focus on embedded health economic analyses within major multicenter trials like BASIL-2 (vascular surgery), PROMPPT (opioid management), and WILL (obstetric hypertension), emphasizing real-world resource allocation and patient-centered outcomes.

Dr. Kigozi actively secures and manages research funding through the UK's National Institute for Health Research:

• Principal Investigator: TREADON trial (NIHR, 2022-2026) on plantar heel pain treatments
• Co-Investigator: COMBINER trial (bipolar disorder, 2024-2030), Medal Trial (low back pain, 2023-2028), PTABIT (thyroid tumors, 2022-2027)

He collaborates extensively with interdisciplinary consortia including the BASIL-2 Investigators, PROMPPT Team, and HIT trial team, driving evidence-based practice through methodologically rigorous health services research.